Evidence map›Paper›PMID 37711953›Full record

ArticleCureus2023

Nosocomial SARS-COVID-19 Outbreak During the Third Wave of COVID-19 in an Oncology Facility at a Tertiary Care Hospital in Kashmir, India.

Farhana Siraj, Mohmad Hussain Mir, Nazia Mehfooz, Karan Happa, Mushtaq Ahmad Sofi, Nisar Ahmad Syed, Faisal Guru, Saquib Z Banday, Nazir Ahmad Dar, Rafi A Jan

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Farhana SirajInternal Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.
Mohmad Hussain MirMedical Oncology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.
Nazia MehfoozPulmonology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.
Karan HappaInternal Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.
Mushtaq Ahmad SofiRadiation Oncology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.
Nisar Ahmad SyedMedical Oncology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.
Faisal GuruMedical Oncology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.
Saquib Z BandayMedical Oncology, State Cancer Institute, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.
Nazir Ahmad DarRadiation Oncology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.
Rafi A JanInternal Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) emerged as a life-threatening respiratory condition, especially in immunocompromised patients, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Initially detected in China in December 2019, the first case in India was diagnosed on January 30, 2020. Here we report a nosocomial COVID-19 outbreak among cancer patients and healthcare workers (HCWs) in a medical oncology unit of a tertiary care hospital from our region. MATERIALS AND

methodsThis was a descriptive study of the nosocomial COVID-19 outbreak and was conducted in the month of January 2022 at the medical oncology unit of a tertiary care hospital in Srinagar, Jammu and Kashmir (J&K), India. The study included 25 COVID-19 cases, including patients and HC/non-HCWs (NHCWs). The confirmation of diagnosis was done through real-time polymerase chain reaction (RT-PCR) using nasopharyngeal/oropharyngeal swabs as the test sample.

resultsTwenty-five COVID-19 cases, including 14 admitted patients, nine HCWs, and two NHCWs were confirmed by COVID-19 RT-PCR in a span of 11 days. The first case was a positive HCW. The patients were admitted for management of various hematological as well as solid organ malignancies. Of the 14 patients, eight were in the pediatric age group with a mean age of 6.9 years, and six were adults with a mean age of 55.2 years. Thirteen patients were on different chemotherapy protocols, and one was undergoing an autologous stem cell transplant. Of the 14 patients, four were asymptomatic for COVID-19 symptoms, eight had mild disease, and two had severe disease with respiratory failure. Two patients with severe diseases needed COVID-19-designated high-dependency unit (HDU) admission. There was one COVID-19-related death. Among the healthcare workers, the mean age was 33.8 years, of which six were males and three were females. All the HCWs and NHCWs had mild disease, and all of them recovered completely.

conclusionNosocomial COVID-19 illness is a new entity and is preventable. COVID-19 illness will remain in society after the pandemic is over, like the influenza B viral illness, and there can be seasonal flares in the future. Proper measures should be taken to prevent its clustering in hospital settings.

Indexed as

covid-19 illnesshealthcare workersimmunocompromisednosocomial covidsars-cov-2

Identifiers

PMID37711953
PMCPMC10499056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.